ArticleOncotarget2019

Optimal targeting of BCL-family proteins in head and neck squamous cell carcinoma requires inhibition of both BCL-xL and MCL-1.

Thomas J Ow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.